Medicine is one of the highest achievements of the human species and graphene is about to play its part in the most recent and exciting developments in the discipline; that is in the emerging domain of nanomedicine. Concerns for health and well-being have inspired some of the boldest innovations in history and nanomedicine continues in the great tradition of these pioneering advances. Born of interdisciplinary work in the fields of bioengineering, physics, chemistry and medicine, nanomedicine is increasingly looking to the material properties of graphene to assist in some of its most interesting projects.
An attempt to preserve China’s position in the graphite marketplace by restricting supplies may cause a welcome increase in the share price of companies around the globe. With a market share of nearly 80% China is hoping to retain as much of its supply as possible, aiming in the long run to gain a stronger position as graphene and graphite based products become more commonplace.
The Chinese curtailment of its supply will inevitably cause smaller mining companies and suppliers to flourish in the short term. One such company Archer Exploration (ASX:AXE), an Australian mining firm, anticipate a rise in the price of the raw material.
Two weeks have passed since I last looked at the fantasy investments in graphene and diamond. For those that don’t remember or weren’t paying attention, an imaginary sum of £1000 and $1000 was invested in two companies, Paragon Diamonds and CVD equipment. Both had shown sizeable loses in the first two weeks causing me to prophecy that a rebound in share price was on the way. The global markets have been hit hard in the intervening weeks, with Europe on the brink of collapse, but how have the new tech and its elder sister fared?
Vorbeck materials has secured investments totalling $10 million in the latest round of a fully subscribed series three funding, proving that the company’s innovations in the graphene marketplace continue to impress. Three investors, Black Powder, LLC and Fairbridge Venture Partners, LP proved dominant in the latest approach for funds, which included 15 additional investors.
The investments will enable Vorbeck to continue its work on new materials technology and should hopefully lead to the development of some inspired design ideas. The company is currently a leader in the manufacture of single sheet graphene and the first company in the world with graphene-based products in the market. As such Vorbeck can be said to be not only the market leader but the whole graphene product market entire. With the additional distinction of being the only company to have received EPA approval for the commercial production and sale of graphene-based products it will be some time before those companies that are following Vorbeck’s lead ever catch up.
IBM (NYSE: IBM) scientists today unveiled several exploratory research breakthroughs that could lead to major advancements in delivering dramatically smaller, faster and more powerful computer chips.
For more than 50 years, computer processors have increased in power and shrunk in size at a tremendous rate. However, today’s chip designers are hitting physical limitations with Moore’s Law, halting the pace of product innovation from scaling alone. With virtually all electronic equipment today built on complementary-symmetry metal–oxide–semiconductor (CMOS) technology, there is an urgent need for new materials and circuit architecture designs compatible with this engineering process as the technology industry nears physical scalability limits of the silicon transistor.